Linear Clinical Research
Linear Clinical Research is Australia’s most trusted clinical trial provider, dedicated to advancing human health through access to innovative therapies. They operate state-of-the-art facilities and have extensive experience in early-phase clinical trials, including cancer, pain management, and COVID-19 vaccines. Their mission is to support global medical breakthroughs by conducting high-quality, efficient, and safe clinical trials in Australia, leveraging generous R&D incentives, fast ethics approval, and a robust infrastructure. They collaborate with top pharmaceutical and biotechnology companies, providing tailored solutions from trial design to delivery, with a focus on speed, quality, and participant safety.
Industries
Nr. of Employees
medium (51-250)
Linear Clinical Research
Perth, Western Australia, Australia, Oceania
Services
Full-service conduct of early- and later-phase clinical trials including inpatient healthy volunteer studies and patient trials in oncology and haematology.
Services to reduce start-up timelines including rapid ethics submissions, CTN/TGA pathway guidance and concurrent site set-up to enable faster site activation.
End-to-end data capture, CDISC-compliant standardisation, query resolution, and provision of audit-ready datasets with real-time dashboards for safety and progress monitoring.
Targeted recruitment using a large pre-screened participant database plus digital marketing and segmentation to accelerate enrolment and improve retention.
Internal technical laboratory capabilities for sample stabilisation and PBMC processing prior to shipment to bioanalytical partners.
Coordination with imaging providers (PET/MRI/CT/X‑ray) and access to specialist testing across multiple clinical specialties.
Full-service conduct of early- and later-phase clinical trials including inpatient healthy volunteer studies and patient trials in oncology and haematology.
Services to reduce start-up timelines including rapid ethics submissions, CTN/TGA pathway guidance and concurrent site set-up to enable faster site activation.
End-to-end data capture, CDISC-compliant standardisation, query resolution, and provision of audit-ready datasets with real-time dashboards for safety and progress monitoring.
Targeted recruitment using a large pre-screened participant database plus digital marketing and segmentation to accelerate enrolment and improve retention.
Internal technical laboratory capabilities for sample stabilisation and PBMC processing prior to shipment to bioanalytical partners.
Coordination with imaging providers (PET/MRI/CT/X‑ray) and access to specialist testing across multiple clinical specialties.
Expertise Areas
- Clinical trial management (Phase I–III)
- First-in-human and healthy volunteer studies
- Oncology and haematology clinical research
- Vaccine clinical development
Key Technologies
- eSource clinical data capture platforms
- CDISC data standards
- Real-time trial dashboards and monitoring
- PBMC processing
News & Updates
Linear’s Rapid Ethics Approval Achievements
In 2024, 94% of cohorts were dosed on schedule, with ethics approval achieved in just 4-6 weeks for early-phase trials.
Linear’s Cost and Speed Advantages in Australia
Partnering with Linear allows sponsors to save up to 60% on trial costs and accelerate development timelines, with streamlined regulatory processes and generous R&D incentives.
Linear’s State-of-the-Art Facilities in Perth
Linear operates advanced clinical centers in Nedlands and Joondalup, equipped for Phase 1-3 trials, vaccine studies, and healthy volunteer research.
Participant Testimonials and Success Stories
Participants highlight the professional staff, amenities, and positive experiences at Linear’s clinics, contributing to medical research and breakthroughs.
High On-Time Dosing Rate in 2024
94.5% of cohorts dosed on time, demonstrating reliability and efficiency in trial execution.
Fast Ethics Approval in 4-6 Weeks
Linear’s streamlined ethics process enables rapid start-up for early-phase trials.
Linear’s Rapid Ethics Approval Achievements
In 2024, 94% of cohorts were dosed on schedule, with ethics approval achieved in just 4-6 weeks for early-phase trials.
Linear’s Cost and Speed Advantages in Australia
Partnering with Linear allows sponsors to save up to 60% on trial costs and accelerate development timelines, with streamlined regulatory processes and generous R&D incentives.
Linear’s State-of-the-Art Facilities in Perth
Linear operates advanced clinical centers in Nedlands and Joondalup, equipped for Phase 1-3 trials, vaccine studies, and healthy volunteer research.
Participant Testimonials and Success Stories
Participants highlight the professional staff, amenities, and positive experiences at Linear’s clinics, contributing to medical research and breakthroughs.
High On-Time Dosing Rate in 2024
94.5% of cohorts dosed on time, demonstrating reliability and efficiency in trial execution.
Fast Ethics Approval in 4-6 Weeks
Linear’s streamlined ethics process enables rapid start-up for early-phase trials.